Cancer biologist and genomics innovator with 15+ years developing and deploying multiomic technologies at the intersection of fundamental discovery and translational oncology. Director of SAIL (core genomics facility) at MSKCC, leads a team of 16 scientists (wet and dry lab) supporting 80+ research programs annually; co-developer of single-cell technologies, h-index 36; NIH co-PI
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Leads a team of 16 scientists supporting 80+ research programs annually; drives platform evaluation and technology adoption across single-cell, spatial, and sample processing modalities.
Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine
Co-developed GoT (Genotyping of Transcriptomes, Nature 2019) and Smart-RRBS (Nature Protocols 2021) for single-cell profiling of DNA methylome, transcriptome, and genotype.
Institut Curie
Demonstrated epigenetic instability of the inactive X chromosome in breast cancer; developed expertise in cancer epigenetics and chromatin regulation.
Institut Gustave Roussy / Université Paris XI
Identified MPL W515L/K mutations in hematopoietic stem cells as disease-initiating events in myeloproliferative neoplasms.
Hourly rate
$1000